We got some love in Japan regarding the second article in Nature.
https://aasj.jp/news/watch/24633
Last paragraph translation:
I didn't expect MSC to be made from iPS cells and made into a product when I was active, but using the fact that I can increase cells almost infinitely at the iPS cell stage, it was difficult to realise with cell therapy, complete one type of cell product that can be used all over the world. I think the most important point is to make it happen. I think the FDA's approval is probably near, so I'm happy that an iPS cell-derived cell product that can be used for universal use has finally been born.
Ann: Further GvHD Clinical Data Published in Nature Medicine, page-11
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 19.0¢ | $5.809K | 29.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48825 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.21pm 07/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |